GlassScriptPhysician profile
Ethan M Henderson
NPI 1447817788
$2,837.19
in general payments reported to CMS, 2019-2025
14 companies · $696 in 2025
The $696 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $722 · 2022: $496 · 2023: $549 · 2024: $374 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $606.37 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $523.05 | 2021-2023 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $365.51 | 2022-2025 | Collagenase Santyl |
| Mimedx Group, INC. | $364.72 | 2025 | |
| Kci USA, INC. | $314.26 | 2021-2023 | Activ.A.C., 3m Cavilon, V.A.C. Veraflo Cleanse Choice |
| Solventum Corporation | $264.98 | 2024-2025 | Activ.A.C., V.A.C. Veraflo Cleanse Choice, Promogran Prisma |
| Molnlycke Health Care US, LLC | $124.18 | 2022 | |
| Davol INC. | $119.34 | 2024 | Phasix Mesh |
| Bsn Medical INC | $40.72 | 2025 | |
| Organogenesis INC. | $34.03 | 2025 | Apligraf |
| Next Science LLC | $25.34 | 2024 | Surgx, Xperience, Blastx |
| Aroa Biosurgery Incorporated | $22.49 | 2023 | |
| Hartmann USA, INC. | $19.25 | 2024 | Zetuvit Plus 10x10 P10 |
| 180 Medical, INC. | $12.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.